Clinical Trial Update: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the pharmacokinetics, safety, and tolerability of single and multiple doses of rasagiline in Parkinson's disease. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED